Cabot (NYSE:CBT) had its price objective lowered by JPMorgan Chase & Co. from $50.00 to $40.00 in a research report report published on Tuesday morning, BenzingaRatingsTable reports. JPMorgan Chase & Co. currently has an overweight rating on the specialty chemicals company’s stock.
Other analysts have also recently issued research reports about the company. TheStreet raised Cabot from a c+ rating to a b- rating in a research report on Friday, July 5th. Loop Capital cut Cabot from a buy rating to a hold rating and lowered their price objective for the stock from $69.00 to $41.00 in a research report on Monday, August 5th. ValuEngine raised Cabot from a strong sell rating to a sell rating in a research report on Thursday, April 18th. Zacks Investment Research cut Cabot from a hold rating to a sell rating and set a $42.00 price objective for the company. in a research report on Friday, August 9th. Finally, Northcoast Research set a $45.00 price objective on Cabot and gave the stock a buy rating in a research report on Wednesday, August 7th. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company’s stock. Cabot has a consensus rating of Hold and an average target price of $48.80.
Shares of NYSE CBT opened at $38.99 on Tuesday. The company has a debt-to-equity ratio of 0.83, a current ratio of 2.07 and a quick ratio of 1.27. The company has a market cap of $2.23 billion, a PE ratio of 9.67, a PEG ratio of 0.96 and a beta of 1.48. Cabot has a 12-month low of $37.11 and a 12-month high of $67.02. The firm’s fifty day moving average is $44.47.
The company also recently announced a quarterly dividend, which will be paid on Friday, September 13th. Investors of record on Friday, August 30th will be paid a $0.35 dividend. The ex-dividend date is Thursday, August 29th. This represents a $1.40 dividend on an annualized basis and a yield of 3.59%. Cabot’s dividend payout ratio (DPR) is 34.74%.
Hedge funds have recently modified their holdings of the stock. Investors Research Corp purchased a new position in shares of Cabot during the 1st quarter valued at about $30,000. Synovus Financial Corp purchased a new position in shares of Cabot in the 1st quarter valued at about $30,000. Twin Tree Management LP purchased a new position in shares of Cabot in the 1st quarter valued at about $30,000. Private Capital Group LLC increased its stake in shares of Cabot by 238.6% in the 1st quarter. Private Capital Group LLC now owns 799 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 563 shares in the last quarter. Finally, Machina Capital S.A.S. increased its stake in shares of Cabot by 409.2% in the 2nd quarter. Machina Capital S.A.S. now owns 998 shares of the specialty chemicals company’s stock valued at $48,000 after purchasing an additional 802 shares in the last quarter. Institutional investors own 86.88% of the company’s stock.
Cabot Company Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and compounds of carbon black and rubber.
Featured Story: How to Invest in Marijuana Stocks
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.